www.fdanews.com/articles/199484-oxford-nanopores-covid-19-test-cleared-in-europe
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
Oxford Nanopore’s COVID-19 Test Cleared in Europe
October 12, 2020
Oxford Nanopore has earned a CE mark certification for its LamPORE COVID-19 test, a diagnostic that is run on the company’s desktop GridION system.
The rapid, low-cost test can be used in any laboratory and the desktop system can process up to 480 samples per run, the company said.
In a study of more than 500 samples, the test showed a sensitivity of 99.1 percent for correctly identifying positive samples and a specificity of 99.6 percent for accurately detecting negative samples.